Li Wan

Prof. Li Wan

Chengdu University of Traditional Chinese Medicine
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZLZheyu Li
Zheyu Li
SLShibo Lin
Shibo Lin
SASiyi An
Siyi An
LLLu Liu
Lu Liu
Yichen HuYichen Hu
Yichen Hu
LWLi Wan
Li Wan

10 October 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RLRuiyu Li
Ruiyu Li
FLFei Luan
Fei Luan
YZYunyan Zhao
Yunyan Zhao
MWMengyao Wu
Mengyao Wu
YLYang Lu
Yang Lu
LWLi Wan
Li Wan

1 December 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
XQXiang Qiu
Xiang Qiu
LZLv Zhu
Lv Zhu
HWHuan Wang
Huan Wang
YTYan Tan
Yan Tan
ZYZhuang Yang
Zhuang Yang
LWLi Wan
Li Wan

17 February 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JZJiajia Zhao
Jiajia Zhao
RWRui Wu
Rui Wu
PWPanhong Wei
Panhong Wei
ZMZiyan Ma
Ziyan Ma
HPHeying Pei
Heying Pei
LWLi Wan
Li Wan

1 November 2020 in Fitoterapia
Verified
Journal Article
Closed access
HNHeng-Fan Ni
Heng-Fan Ni
XCXiaoying Cai
Xiaoying Cai
XQXiang Qiu
Xiang Qiu
LLLin Liu
Lin Liu
XMXu Ma
Xu Ma
LCLijuan Chen
Lijuan Chen

19 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RWRui Wu
Rui Wu
JZJiajia Zhao
Jiajia Zhao
PWPanhong Wei
Panhong Wei
MTMinghai Tang
Minghai Tang
ZMZiyan Ma
Ziyan Ma
LWLi Wan
Li Wan
Colorectal cancer (CRC) is a prevalent malignancy of the digestive tract with the second highest mortality rate globally. Piper nigrum is a widely used traditional medicinal plant, exhibiting antitumor activity against various tumor cells. At present, research on the effect of Piper nigrum on CRC is limited to in vitro cytotoxicity, lacking comprehensive mechanism investigations. This study aimed to explore the inhibitory effect and mechanism of Piper nigrum extract (PNE) on HT-29 cells. Firstly, we identified the chemical components of PNE. Then, MTT assay, colony formation assay, JC-1 staining, and flow cytometry were used to analyze the effect of PNE on HT-29 cells in vitro. A xenograft model, histopathological examination, immunohistochemistry, and western blot were used to evaluate the tumor growth inhibitory activity and mechanism of PNE in vivo. The results indicated that PNE could inhibit cell proliferation and colony formation, reduce mitochondrial membrane potential, induce cell apoptosis in vitro, and inhibit tumor growth in vivo. Furthermore, PNE could regulate p53 and its downstream proteins, and subsequently activate the caspase-3 pathway. In summary, PNE probably induced apoptosis of HT-29 cells through the mitochondrial pathway mediated by p53. All these results suggested that PNE might be a potential natural-origin anti-CRC drug candidate.